Navigation Links
Express Scripts HealthBridge Pharma & Biotech to Provide Exclusive Specialty Pharmacy Services and Limited Distribution Services for Solesta®
Date:10/13/2011

ST. LOUIS, Oct. 13, 2011 /PRNewswire/ -- CuraScript, Inc., a wholly owned subsidiary of Express Scripts, Inc., is now the exclusive specialty pharmacy for patients using Solesta®, a product of Oceana Therapeutics Inc., under an agreement announced today. Part of Express Scripts HealthBridge Pharma & Biotech services, CuraScript SD Specialty Distribution will be one of two national distributors responsible for delivering Solesta to healthcare providers.

Solesta is the only nonsurgical treatment approved by the Food and Drug Administration for patients who fail conservative therapy for fecal (bowel) incontinence. A biocompatible tissue-bulking agent, Solesta is an injectable gel administered in an outpatient setting without the need for anesthesia. Oceana Therapeutics has exclusive rights to market, sell and distribute Solesta, a registered trademark of the international medical device company Q-Med AB.

About HealthBridge Pharma & BiotechHealthBridge Pharma & Biotech provides a suite of services offering pharmaceutical and biotech companies a single solution approach to patient care. These services include: CuraScript SP Specialty Pharmacy, CuraScript SD Specialty Distribution, Freedom Fertility Pharmacy, risk evaluation and mitigation strategies (REMS), reimbursement, patient assistance programs (PAP), data and sales reporting, enhanced account services, and customized adherence programs.

As a service of HealthBridge Pharma & Biotech, CuraScript SP Specialty Pharmacy is a wholly owned subsidiary of Express Scripts. CuraScript manages the largest number of exclusive Pharma/Biotech programs in the industry and has been involved in nearly every specialty product launch over the last eight years. CuraScript services more than 1,800 plan sponsors that cover tens of millions of Americans.

CuraScript SD Specialty Distribution, an Express Scripts subsidiary, is a premier provider of comprehensive distribution solutions f
'/>"/>

SOURCE Express Scripts
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Express Scripts Announces Revised 2011 Financial Guidance
2. ChemoMetec and De Novo Software to Co-market NucleoCounter® NC-3000™ and FCS Express 4 Image Cytometry Software
3. Transcriptome Viewer - Comprehensive Genome-wide Map of Human Gene Expression Activity Released for Public by MediSapiens
4. Merger of Express Scripts and Medco Health Solutions Will Address the Bipartisan Mandate for Safer, More Affordable, Higher Quality Healthcare
5. Molecular Devices Announces ImageXpress Micro XL High-Content Screening System
6. Express Scripts to Present at Investor Conferences in September
7. Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
8. Express Scripts and Medco Health Solutions Sign Definitive Merger Agreement; Medco Shareholders to Receive $29.1 Billion
9. Express Scripts Announces Second Quarter 2011 Earnings Conference Call
10. Express Scripts Strives to Make Prescription Drugs Affordable and Accessible to American Families
11. Generex Announces Appointment of CEO for Post-Spinout Antigen Express
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)...  Leadership speaker and business author Mary Kelly, Ph.D ., is helping members of the ... Photo - http://photos.prnewswire.com/prnh/20150420/199849 ... ... ... run a successful medical practice without pulling your hair out of your head or going bankrupt," ...
(Date:4/21/2015)... -- Delcath Systems, Inc. (NASDAQ: DCTH ) announces ... filed with the U.K.,s Medicines and Healthcare ... Germany,s Federal Institute for Drugs and Medical ... Phase 2 program for the treatment of patients with ... include a cohort of patients with intrahepatic cholangiocarcinoma (ICC). ...
(Date:4/21/2015)... , April 21, 2015  The increase ... reforms the market for self-monitoring blood glucose (SMBG) ... limit the revenue potential for this market.  Availability ... and strained participants, profit margins. Photo ... analysis from Frost & Sullivan, US Self-monitoring ...
Breaking Medicine Technology:Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 2Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 3Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 4Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 5Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 2Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 3Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 4Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 2Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 3Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 4
... Cardiac Arrhythmia,Institute (TCAI) at St. David,s Medical Center ... sites in the nation to participate in an ... persistent atrial fibrillation. TCAI, an,international treatment, training and ... partnership between St. David,s Medical Center and,Texas Cardiovascular ...
... adults, VYVANSE taken once-daily significantly,improved the symptoms of ... Shire plc (LSE: SHP,Nasdaq: SHPGY), the global ... in the September issue of the Journal of,Clinical ... Disorder (ADHD) symptoms in adults within,the first week ...
Cached Medicine Technology:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6
(Date:4/21/2015)... (PRWEB) April 21, 2015 Autocarsinsurancetips.com has ... low cost auto insurance plans by comparing ... drivers to find the best policies in their neighborhood. ... find the next best offer simply by comparing different ... by using online car insurance quotes. Insurance brokerage websites ...
(Date:4/21/2015)... Block Island, RI (PRWEB) April 21, 2015 ... the fountain of youth through fancy products and complex routines ... believes in skin care through suncare, not gimmicks, as the ... aging. Simply put, good suncare is more than just ... skin at all hours. Block Island Organics’ new Purifying ...
(Date:4/21/2015)... eMindful, the provider of ... Gallagher as senior vice president of sales. Gallagher has ... leadership roles with major health insurance carriers, health care ... he managed national accounts for The Vitality Group, a ... consistently a top producer, sales manager and executive for ...
(Date:4/21/2015)... 2015 A new study at a ... with peritoneal cancers like mesothelioma increased by 20 percent ... posted the results of the study. Click here ... at North Hampshire Hospital in Basingstoke performed a retrospective ... such as mesothelioma between 1994 and 2014. They ...
(Date:4/21/2015)... IN (PRWEB) April 21, 2015 ... employee benefits advisory organization, is pleased to welcome ... Firm. Since 1991, Mark Kunkle and Jeff Power ... of service earning the confidence of more than ... means innovative thinking, strategic planning, dedicated stewardship, ethical ...
Breaking Medicine News(10 mins):Health News:Online Auto Insurance Quotes Can Help Clients Save Money 2Health News:Block Island Organics Debunks Skin Care Myths with New Products 2Health News:Block Island Organics Debunks Skin Care Myths with New Products 3Health News:eMindful Continues to Expand Executive Leadership Team With Employee Benefits Sales Executive Michael Gallagher 2Health News:New Findings Highlight Value of Experience in Peritoneal Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Power Kunkle Benefits Consulting Is the Latest Partner Firm To Join United Benefit Advisors 2
... May 29 (HealthDay News) -- ,Adult survivors of childhood ... life because of the long-term physical effects of their ... data from the Childhood Cancer Survivor Study to assess ... experienced by more than 14,000 adult survivors of childhood ...
... , TUESDAY, May 29 (HealthDay News) -- Should the ... study suggests their inclusion may be warranted. The study ... are more likely to survive than those who refuse such ... lives of patients who receive smokers, lungs, however, tended to ...
... often first presents in newborn babies has been traced to ... London have found. The research, published online in ... a specific gene found in patients with the rare adrenal ... means affected children are unable to produce a hormone called ...
... mutation responsible for IMAGe syndrome, a rare disorder that stunts ... gene that causes BeckwithWiedemann syndrome, which makes cells grow too ... in the May 27 edition of the journal Nature Genetics, ... the rapid cell division that allows tumors to grow unchecked. ...
... and explanation" of the REMARK (Reporting Recommendations for Tumor ... of Oxford, UK and colleagues provide a detailed reference ... conducting, analyzing and reporting tumor marker prognostic studies. Writing ... in BMC Medicine ) the authors explain the ...
... 2012 Older adults who don,t get enough vitamin D ... be at increased risk of developing mobility limitations and disability, ... , "This is one of the first studies to look ... new mobility limitations or disability in older adults," said lead ...
Cached Medicine News:Health News:Emotional Woes May Last for Childhood Cancer Survivors 2Health News:Use of Smokers' Lungs for Transplant Has Pros, Cons 2Health News:Use of Smokers' Lungs for Transplant Has Pros, Cons 3Health News:Disease that stunts infants' growth traced to same gene that makes kids grow too fast 2Health News:Disease that stunts infants' growth traced to same gene that makes kids grow too fast 3Health News:Disease that stunts infants' growth traced to same gene that makes kids grow too fast 4Health News:Older adults may need more vitamin D to prevent mobility difficulties 2
The SYNCHRON CX7-S workstation offers a broad menu, advanced data management and more. Targeted to the mid-volume lab, the CX7-S is easy to use, easy to maintain and easy to acquire....
... workstation offers a broad menu, ... the mid-size lab that processes ... day. Like all SYNCHRON CX-S ... to use, easy to maintain ...
... for the high-volume lab, the SYNCHRON LX4201 ... performing up to 2,880 tests per hour. ... the SYNCHRON LX4201 with broad menu, speed ... you've come to expect from Beckman Coulter-innovative, ...
... technology to increase laboratory efficiency ... lower costs. It takes the ... features that you will not ... analyzer, including closed tube sampling ...
Medicine Products: